1 |
Wittmann HG. Structure and evolution of ribosomes. Mol Biol Biochem Biophys. 1980;32:376-397. [PMID: 7003352 DOI: 10.1186/s12943-019-1126-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 0.7] [Reference Citation Analysis]
|
2 |
Yu J, Wang JQ. Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases. Biochimie 2021;180:149-57. [PMID: 33166595 DOI: 10.1016/j.biochi.2020.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
3 |
Liao H, Shi J, Wen K, Lin J, Liu Q, Shi B, Yan Y, Xiao Z. Molecular Targets of Ferroptosis in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:985-96. [PMID: 34466409 DOI: 10.2147/JHC.S325593] [Reference Citation Analysis]
|
4 |
Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, Neureiter D. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers (Basel) 2022;14:1826. [PMID: 35406596 DOI: 10.3390/cancers14071826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Wei J, Gao X, Qin Y, Liu T, Kang Y. An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer. Onco Targets Ther 2020;13:12763-75. [PMID: 33363382 DOI: 10.2147/OTT.S287811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|